NFKB1 and prostate carcinoma: Treatment of PC-3 or LNCaP prostate cancer cells with dentatin blocked NF-κB translocation and resulted in accumulation of NF-κB in the cytoplasm after TNF-α stimulation (Figure 10(a)).